期刊文献+

血清白蛋白对食管癌放疗患者生存时间的影响 被引量:5

Influence of serum albumin on the survival time of esophageal cancer patients with radiotherapy
原文传递
导出
摘要 目的:探讨血清白蛋白对食管癌放疗患者生存时间的影响,为食管癌患者的放疗敏感性提供判断依据。方法收集接受放射治疗的食管癌患者365例,对其进行随访观察,采用Kaplan-Meier法及Log-rank检验进行生存分析,并以Cox回归进行多因素分析。结果男性、TNM Ⅲ~Ⅳ期、淋巴结转移、放疗并发症、血清白蛋白≤40 g/L是食管癌放疗患者生存时间的独立危险因素[HR(95%CI)分别为1.539(1.121~2.114),1.734(1.125~2.674),1.763(1.308~2.376),1.642(1.220~2.211),2.162(1.616~2.893)]。结论血清白蛋白水平可以预测食管癌放疗癌患者的生存时间,血清白蛋白水平≤40 g/L者的生存时间明显短于﹥40 g/L者。性别、TNM分期、淋巴结转移、放疗并发症是影响食管癌放疗患者生存时间的独立危险因素。 Objective To explore the effect of serum albumin on the survival time of esophageal cancer patients treated by radiotherapy,and to provide reference for sensitivity assesment of esophageal cancer patients treated by radiotherapy. Methods Data of 365 esophageal cancer patients treated with radiotherapy were collected. The patients were followed up. The survival analysis was performed by Kap-lan-Meier method and Log-rank test,and Cox regression was used for multivariate analysis. Results Sex ( male),TNM stage Ⅲ -Ⅳ,lymph node metastasis,radiotherapy complications,albumin≤40 g/L were independent risk factors for survival time of patients with esophageal cancer after radiotherapy[ HR (95%CI)were 1. 539(1. 121 -2. 114),1. 734(1. 125 -2. 674),1. 763(1. 308 -2. 376),1. 642 (1. 220-2. 211),and 2. 162(1. 616-2. 893)respectively]. Conclusions The serum albumin level can predict the survival time of patients with esophageal cancer undergone radiotherapy,and survival time of the patients with albumin level below 40 g/L was significantly lower than whose the albumin level a-bove 40 g/L. Sex,TNM stage,lymph node metastasis and radiotherapy complications were independent risk factors for survival time in patients with esophageal cancer.
出处 《中国实用医刊》 2016年第16期17-19,共3页 Chinese Journal of Practical Medicine
基金 河南省科技厅重点科技攻关项目(142102310502)
关键词 血清白蛋白 食管癌 放疗 生存时间 Serum albumin Esophageal cancer Radiotherapy Survival time
  • 相关文献

参考文献18

  • 1Tone LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012 [ J ]. CA Cancer J C1in,2015,65 (2) :87-108. 被引量:1
  • 2Ciocirlan M, Lapalus MG, Hervieu V, et al. Endoscopic mucosal re- section for squamous premalignant and early malignant lesions of the esophagus[ J ]. Endoscopy,2007,39 ( 1 ) :24-29. 被引量:1
  • 3Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003 -2005 : a population-based study [ J ]. Int J Cancer, 2015,136 (8) : 1921-1930. 被引量:1
  • 4McMillan DC, Watson WS, O' Gorman P, et al. Albumin concentra- tions are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss[ J]. Nutri- tion and Cancer,2001,39(2) :210-213. 被引量:1
  • 5Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cane- er survival : a systematic review of the epidemiological literature [ J ]. Nutr J, 2010,9:69. 被引量:1
  • 6Onate-Ocana LF, Aiello-Crocifogiio V, Gallardo-Rineon D, et al. Se- rum albumin as a significant prognostic factor for patients with gastric carcinoma[ J]. Annals of Surgical Oncology,2007,14(2) :381-389. 被引量:1
  • 7Sun LC, Chu KS, Cheng SC, et al. Preoperative serum carcinoem- bryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment[ J]. BMC Cancer,2009,9:288. 1. 被引量:1
  • 8Ruiz-Tovar J, Martin-Perez E, F ME, et al. Im- pact of preoperative levels of hemoglobin and albumin on the survival of pancreatic carcinoma [ J ]. Rev Esp Enferm Dig, 2010,102 ( 11 ) : 631-636. 被引量:1
  • 9Lai CC, You JF, Yeh CY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome [ J ]. Int J Colorectal Dis, 2011,26 (4) :473-48. 被引量:1
  • 10施贵冬,罗志林,付茂勇,田东,张霖,张科平.国际抗癌联盟一美国癌症联合委员会第7版食管癌和胃癌TNM分期系统在预测食管胃交界腺癌Siewert Ⅱ型患者预后中的价值[J].中华肿瘤杂志,2014,36(12):916-921. 被引量:21

二级参考文献35

  • 1樊宏伟,丁小琳.胃窦癌与贲门癌幽门螺旋杆菌感染的胃内分布特点[J].中国误诊学杂志,2005,5(3):477-478. 被引量:3
  • 2Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration [J]. Dis Esophagus, 2009, 22 (1):1- 8. 被引量:1
  • 3Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world[J]. Ann Surg. 20(H ,234(3) :360- 367; discussion 368-369. 被引量:1
  • 4Eloubeidi MA, Desmond R, Arguedas MR. et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U. S. : the importance of tumor length and lymph node status[J]. Cancer, 2002,95(7):1434-1443. 被引量:1
  • 5Bogoevski D, Onken F, Koenig A, et al. Is it time for a new TNM classification in esophageal carcinoma7 [J]. Ann Surg, 2008,247(4) :633-641. 被引量:1
  • 6Rizk N, Venkatraman E, Park B, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system[J]. J Thorac Cardiovasc Surg, 2006,132(6) : 1374-1381. 被引量:1
  • 7International Union Against Cancer. Oesophagus[M]//Sobin L H, Wittekind C (eds). TNM classification of malignant tumors, 6th edn. New York: Wiley-Liss,2002:60-64. 被引量:1
  • 8Fujita H, Sueyoshi S, Tanaka T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy[J]. World J Surg, 2003, 27 (5) : 571-579. 被引量:1
  • 9Siewert JR, Stein HJ. Lymph-node dissection in squamous cell esophageal cancer-who benefits?[J].. Langenbecks Arch Surg, 1999,384(2) : 141-148. 被引量:1
  • 10Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer [J]. Oncology, 1991,48(5) :411-420. 被引量:1

共引文献26

同被引文献33

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部